For Research Use Only. Not for Use in Diagnostic Procedures.
High Content Screening Scientific Posters
Although the intention of high content screening is to extract as much relevant information as possible, a large percentage of high content screening assays only analyze a small number of image based properties. Here we show how nuclear staining can be used to differentiate cell lines from each other without any further staining or phenotypic markers, leveraging the high quality images derived from either the Opera Phenix™ or Operetta CLS™ systems in combination with the advanced texture and morphology tools of Harmony® High Content Imaging and Analysis Software.
FRET-based imaging assays are widely utilized to study protein-protein interactions or signal transduction processes in living cells. Here, we present a high content imaging assay to study the interaction between the pro-apoptotic protein Bad and the anti-apoptotic protein Bcl-XL in living MCF7 cells.
We present a High Content Screening application to analyze the integrity of the podocyte actin cytoskeleton. Using the Operetta® High Content Imaging System we acquired images of podocytes grown on CYTOO chips™ and analyzed drug-induced changes in podocyte morphology using the Harmony® High Content Imaging and Analysis Software.
Here, we show how a combination of a biochemical assay, using AlphaLISA® technology, and a cell based high content assay with the Operetta® High Content Imaging System, can be used for identification of HDAC inhibitors. The approach presented demonstrates the potential power of combinatorial screening campaigns using the advantages of both target-based and phenotypic approaches.
We show how the boundaries of microtissue imaging can be pushed further by using the Opera® High Content Screening System (equipped with a water objective lens) in combination with a microtissue pre-treatment. The Scale aqueous reagent renders the biological sample optically more transparent and allows a greater imaging depth.
3D cell culture methods are widely accepted as being more physiologically relevant than conventional 2D cell culture methods and are believed to improve the prediction of drug candidates at an early stage in the drug development process. In this study we describe the analysis of a spherical colon cancer microtissue model using the Operetta® High Content Imaging System.
Here, we present a high content analysis (HCA) based assay to study NF-kB signaling in living cells using the Operetta® High Content Imaging System and the Promega HaloTag® technology. By analyzing the acquired Operetta images with our Acapella® High Content Imaging and Analysis Software, we were able to track individual cells over time.
We utilized the HCA ImagAmpTM reagent kit in: (1) two typical high content analysis (HCA) assays for cytotoxicity, and in (2) a specific epigenetic assay monitoring the modulation of dimethylated lysine 9 residue on histone H3 (H3K9me2). Signal amplification with HCA ImagAmp is achieved through enzyme-mediated deposition of multiple fluorophores in close proximity to a given antigen.
Here we demonstrate a successful automation of the sample preparation of Platypus Technologies’ Oris™ Pro Cell Migration Assay on a PerkinElmer JANUS® Automated Workstation. Analysis of cell migration using the Operetta® High Content Imaging System and the EnSpire® Multimode Plate Reader shows the assay to be a robust and reproducible quantification of cell motility.
Here we demonstrate use of TSA for quantification of PKCαin unstimulatedand stimulated HeLacells using the Operetta® High Content Imaging System.
To investigate drug-induced cytotoxicity we used cryopreserved single-donor hepatocytes seeded into microplates in a conventional monolayer and treated them with three model hepatotoxins. After applying a convenient no-wash staining protocol live cells were imaged directly on the Operetta® High Content Screening System.
In this study we describe how single live cells can be followed through the entire cell cycle using a specific cell cycle protein binding cameloid antibody (Chromobody®) tagged with GFP (green fluorescent protein).
Cell migration plays a major role in a variety of physiological events, such as immune response and wound healing. It also contributes to pathological processes such as metastasis. Understanding the molecular components of migration is crucial for discovering new targets to develop drugs that affect migration.
Previous research in basic and clinical neurosciences has improved the understanding of genetic disturbances associated with human neurodegenerative disease, which has permitted the generation of an increasing number of transgenic mouse models of Alzheimers disease, Parkinson disease and amyotrophic lateral sclerosis (ALS). Although the stru ctural and functional analysis of existing models has generated important insights, the detailed investigation of pathophysiological signal pathways in each mouse model remains a time – consuming challenge.
The characterization of agents that inhibit cell proliferation and division is particularly important for drug discovery research. Both events can be analyzed using HCS approaches by multiplexing cell cycle-specific cellular targets. One technique is EdU staining, which detects the S-phase of the cell cycle through incorporation of the nucleoside analog Uridine into newly synthesized DNA strands. Furthermore, there are well validated protein markers available that are associated with certain cell cycle phases.
Cytotoxicity is a very complex process affecting multiple pathways and is not manifested by determining one morphological parameter. However, the ability to measure early indicators of toxicity is an essential part of drug discovery. Cell-based High Content Applications are a powerful tool for determining several events in cytotoxicity simultaneously. We describe a rapid and flexible dye-based high content cytotoxicity assay performed with the widely-used HepG2 (human hepatocellular carcinoma) cells.
One of the most important tasks in anticancer treatment is the inhibition of cell proliferation by interruption of the cell cycle. As the cell cycle is subdivided into the four phases G1-, S-, G2- and M-phase, there are diverse targets for arresting cells either during DNA replication in S-phase or during division in mitosis. Several cytoplasmic proteins like the cyclines have been identified to be proprietary in cell cycle control whereas Cyclin B1 in particular is essential for initiation of mitosis.
Apoptosis – the genetically coded program leading to the self-destruction of a cell – can be induced via two main pathways, the death receptor-mediated pathway, and the mitochondrial pathway. Induction of either finally results in the activation of caspases, a class of intracellular cytokine proteases which are considered to be the central components of the apoptotic response. By breaking down key cellular components that are required for maintaining normal cellular functions caspases are responsible for executing morphological and biochemical consequences directly or indirectly attributed to apoptosis.
G-protein coupled receptors (GPCRs) are an attractive drug target for several clinically relevant disorders. This is primarily due to their membrane location, ubiquitous expression and critical involvement in many mammalian physiological systems. While several assays targeted at downstream GPCR signalling events have allowed characterization of this receptor superfamily, there are few non-invasive techniques that allow analysis of the receptor-ligand interaction at the cellular level.